Insider · CIK 0001750132

Gibney Anthony S

Reports to the SEC for 5 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001750132

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	AURAAura Biosciences, Inc.S Sale	See Remarks	SSale	−12.8K sh	$6.42	−$82.3K	265,354
2026-03-02	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+129K sh	—	—	128,755
2026-03-02	AURAAura Biosciences, Inc.A Award	See Remarks	AAward	+71.2K sh	—	—	278,178
2025-06-02	AURAAura Biosciences, Inc.A Award	See Remarks	AAward	+150K sh	—	—	206,933
2025-06-02	AURAAura Biosciences, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+250K sh	—	—	250,000
2025-05-16	AURAAura Biosciences, Inc. · Common Stock Warrants (right to buy)P Purchase	See Remarks	PPurchase	+12.5K sh	—	—	12,500
2025-05-16	AURAAura Biosciences, Inc.P Purchase	See Remarks	PPurchase	+50K sh	$4.90	+$245K	58,452
2025-05-16	AURAAura Biosciences, Inc.S Sale	See Remarks	SSale	−1,519 sh	$5.15	−$7,822.85	56,933
2024-06-20	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-04-18	CLSDQClearside Biomedical, Inc.P Purchase	Director	PPurchase	+93.3K sh	$1.30	+$121K	100,000
2024-04-17	CLSDQClearside Biomedical, Inc.P Purchase	Director	PPurchase	+6,710 sh	$1.25	+$8,387.5	6,710
2024-04-15	CLSDQClearside Biomedical, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	EVP, Chief Business Officer	DDisposition to Issuer	−200K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	EVP, Chief Business Officer	DDisposition to Issuer	−50K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Business Officer	DDisposition to Issuer	−75K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Business Officer	DDisposition to Issuer	−25K sh	—	—	0
2023-07-11	IVERIC bio, Inc.D Disposition to Issuer	EVP, Chief Business Officer	DDisposition to Issuer	−40.3K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, Chief Business Officer	DDisposition to Issuer	−56.3K sh	—	—	0
2023-06-28	IVERIC bio, Inc.G Gift	EVP, Chief Business Officer	GGift	−2,500 sh	—	—	40,291
2022-12-20	IVERIC bio, Inc.Restricted Stock UnitsA Award	EVP, Chief Business Officer	AAward	+25K sh	—	—	25,000
2022-12-20	IVERIC bio, Inc.Stock Option (right to buy)A Award	EVP, Chief Business Officer	AAward	+50K sh	—	—	50,000
2022-12-13	IVERIC bio, Inc.M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+6,000 sh	—	—	17,791
2022-12-13	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−6,000 sh	—	—	0
2022-12-13	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−25K sh	—	—	75,000
2022-12-13	IVERIC bio, Inc.M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+25K sh	—	—	42,791
2022-07-05	IVERIC bio, Inc.S Sale	EVP, Chief Business Officer	SSale	−7,791 sh	$9.41	−$73.3K	10,959
2022-06-30	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	−18.8K sh	—	—	56,250
2022-06-30	IVERIC bio, Inc.M Exercise/Conversion	EVP, Chief Business Officer	MExercise/Conversion	+18.8K sh	—	—	18,750
2021-12-13	IVERIC bio, Inc.Stock Option (Right to Buy)A Award	EVP, Chief Business Officer	AAward	+200K sh	—	—	200,000
2021-12-13	IVERIC bio, Inc.Restricted Stock UnitsA Award	EVP, Chief Business Officer	AAward	+75K sh	—	—	75,000
2021-12-13	IVERIC bio, Inc.Restricted Stock UnitsA Award	EVP, Chief Business Officer	AAward	+6,000 sh	—	—	6,000
2021-12-13	IVERIC bio, Inc.Restricted Stock UnitsA Award	EVP, Chief Business Officer	AAward	+100K sh	—	—	100,000
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	EVP, Chief Business Officer	DDisposition to Issuer	−200K sh	—	—	0
2020-01-28	ACHILLION PHARMACEUTICALS INCStock Options (Right to buy)D Disposition to Issuer	EVP, Chief Business Officer	DDisposition to Issuer	−500K sh	—	—	0
2019-01-23	ACHILLION PHARMACEUTICALS INCStock Option (Right to buy)A Award	EVP, Chief Business Officer	AAward	+200K sh	—	—	200,000
2018-08-15	ACHILLION PHARMACEUTICALS INCEmployee Stock OptionA Award	EVP, Chief Business Officer	AAward	+500K sh	—	—	500,000

Recent filings

Accepted (ET)
Jun 164
Gibney Anthony S0001193125-26-272703
SEC(opens sec.gov)
Mar 34
Gibney Anthony S0001193125-26-088168
SEC(opens sec.gov)
Jun 44
Gibney Anthony S0000950170-25-081616
SEC(opens sec.gov)
May 204
Gibney Anthony S0000950170-25-075403
SEC(opens sec.gov)
Jun 214
Gibney Anthony S0001415889-24-017827
SEC(opens sec.gov)
Apr 194
Gibney Anthony S0001415889-24-011199
SEC(opens sec.gov)
Apr 164
Gibney Anthony S0001415889-24-010873
SEC(opens sec.gov)
Jul 134
Gibney Anthony S0001104659-23-080680
SEC(opens sec.gov)
Jun 304
Gibney Anthony S0001410939-23-000103
SEC(opens sec.gov)
Dec 224
Gibney Anthony S0001410939-22-000145
SEC(opens sec.gov)

Companies

Address

C/O AURA BIOSCIENCES, INC. 80 GUEST STREET

BOSTON, MA, 02135